A Modeling Investigation of the CYP1A Drug Interactions of Riluzole

Documenti analoghi

• Evaluation of Drug–Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants
  di: Alison Luckey, et al.
  Pubblicazione: (2026)
• Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans
  di: Sungyeun Bae, et al.
  Pubblicazione: (2026)
• Population Pharmacokinetic Model Assessment of the Effects of Body Weight on Risk of Drug–Drug Interactions After Posaconazole Discontinuation
  di: Rebecca E. Wrishko, et al.
  Pubblicazione: (2026)
• Navigating Drug–Drug Interactions in Clinical Drug Development: A Tutorial
  di: Jesmin Lohy Das, et al.
  Pubblicazione: (2025)
• Tutorial Drug–Drug Interactions
  di: Edward M. Sellers
  Pubblicazione: (2025)